CN102038715A - 一种中药溶散片剂及制备方法 - Google Patents
一种中药溶散片剂及制备方法 Download PDFInfo
- Publication number
- CN102038715A CN102038715A CN2009100708264A CN200910070826A CN102038715A CN 102038715 A CN102038715 A CN 102038715A CN 2009100708264 A CN2009100708264 A CN 2009100708264A CN 200910070826 A CN200910070826 A CN 200910070826A CN 102038715 A CN102038715 A CN 102038715A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- agent
- dispersible tablets
- low melting
- water soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 94
- 239000007919 dispersible tablet Substances 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims abstract description 41
- 239000000843 powder Substances 0.000 claims abstract description 68
- 239000003826 tablet Substances 0.000 claims abstract description 67
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 50
- 239000000284 extract Substances 0.000 claims abstract description 39
- 238000002844 melting Methods 0.000 claims abstract description 35
- 230000008018 melting Effects 0.000 claims abstract description 34
- 239000000203 mixture Substances 0.000 claims abstract description 31
- 239000000314 lubricant Substances 0.000 claims abstract description 17
- 239000002671 adjuvant Substances 0.000 claims description 51
- 239000011248 coating agent Substances 0.000 claims description 49
- 238000000576 coating method Methods 0.000 claims description 49
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 38
- 239000003795 chemical substances by application Substances 0.000 claims description 29
- 229940079593 drug Drugs 0.000 claims description 25
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000741 silica gel Substances 0.000 claims description 24
- 229910002027 silica gel Inorganic materials 0.000 claims description 24
- -1 fluidizer Substances 0.000 claims description 20
- 235000019359 magnesium stearate Nutrition 0.000 claims description 19
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 14
- 239000008118 PEG 6000 Substances 0.000 claims description 10
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 claims description 10
- 229930006000 Sucrose Natural products 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 239000005720 sucrose Substances 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 6
- 229920001993 poloxamer 188 Polymers 0.000 claims description 6
- 229940044519 poloxamer 188 Drugs 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 229960004793 sucrose Drugs 0.000 claims description 6
- 239000000811 xylitol Substances 0.000 claims description 6
- 235000010447 xylitol Nutrition 0.000 claims description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 6
- 229960002675 xylitol Drugs 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims description 4
- 229920001983 poloxamer Polymers 0.000 claims description 4
- 229960000502 poloxamer Drugs 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 239000004386 Erythritol Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- MXRIRQGCELJRSN-UHFFFAOYSA-N O.O.O.[Al] Chemical compound O.O.O.[Al] MXRIRQGCELJRSN-UHFFFAOYSA-N 0.000 claims description 2
- 229920002507 Poloxamer 124 Polymers 0.000 claims description 2
- 229920002508 Poloxamer 181 Polymers 0.000 claims description 2
- 229920002509 Poloxamer 182 Polymers 0.000 claims description 2
- 229920002511 Poloxamer 237 Polymers 0.000 claims description 2
- 229920002516 Poloxamer 331 Polymers 0.000 claims description 2
- 229920002517 Poloxamer 338 Polymers 0.000 claims description 2
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 claims description 2
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 claims description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical group [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 2
- 239000008116 calcium stearate Substances 0.000 claims description 2
- 235000013539 calcium stearate Nutrition 0.000 claims description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical group O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 229940093448 poloxamer 124 Drugs 0.000 claims description 2
- 229940085692 poloxamer 181 Drugs 0.000 claims description 2
- 229940093426 poloxamer 182 Drugs 0.000 claims description 2
- 229940116406 poloxamer 184 Drugs 0.000 claims description 2
- 229920001992 poloxamer 407 Polymers 0.000 claims description 2
- 229940044476 poloxamer 407 Drugs 0.000 claims description 2
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 16
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 238000002156 mixing Methods 0.000 abstract description 9
- 238000003825 pressing Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 238000005516 engineering process Methods 0.000 description 22
- 238000007689 inspection Methods 0.000 description 11
- 239000007921 spray Substances 0.000 description 11
- 230000003203 everyday effect Effects 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 238000009702 powder compression Methods 0.000 description 8
- 241000208340 Araliaceae Species 0.000 description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 description 7
- 238000007906 compression Methods 0.000 description 7
- 230000006835 compression Effects 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 235000008434 ginseng Nutrition 0.000 description 7
- 229920003023 plastic Polymers 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 239000002552 dosage form Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000010231 banlangen Substances 0.000 description 5
- 230000006837 decompression Effects 0.000 description 5
- 238000007907 direct compression Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 241000628997 Flos Species 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 238000005453 pelletization Methods 0.000 description 4
- 239000007962 solid dispersion Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000007797 corrosion Effects 0.000 description 3
- 238000005260 corrosion Methods 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 229940023488 pill Drugs 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000237903 Hirudo Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000237636 Pheretima Species 0.000 description 2
- 241000522620 Scorpio Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000009490 scorpio Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 241000218176 Corydalis Species 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000217407 Margaritifera Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 229940096978 oral tablet Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910070826.4A CN102038715B (zh) | 2009-10-16 | 2009-10-16 | 一种中药溶散片剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910070826.4A CN102038715B (zh) | 2009-10-16 | 2009-10-16 | 一种中药溶散片剂及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102038715A true CN102038715A (zh) | 2011-05-04 |
CN102038715B CN102038715B (zh) | 2014-01-15 |
Family
ID=43905478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910070826.4A Expired - Fee Related CN102038715B (zh) | 2009-10-16 | 2009-10-16 | 一种中药溶散片剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102038715B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103479992A (zh) * | 2013-10-14 | 2014-01-01 | 张桂赫 | 治疗伴消化道症状的焦虑性神经症的中药丸及其制备方法 |
CN114767823A (zh) * | 2022-04-13 | 2022-07-22 | 黄东生 | 治疗胃痞病的中药及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733137A (zh) * | 2005-08-26 | 2006-02-15 | 贵阳高新瑞得科技开发有限公司 | 颠茄分散片及其制法 |
-
2009
- 2009-10-16 CN CN200910070826.4A patent/CN102038715B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733137A (zh) * | 2005-08-26 | 2006-02-15 | 贵阳高新瑞得科技开发有限公司 | 颠茄分散片及其制法 |
Non-Patent Citations (1)
Title |
---|
朱盛山,等: "中药口服给药新剂型研究进展", 《广东药学院学报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103479992A (zh) * | 2013-10-14 | 2014-01-01 | 张桂赫 | 治疗伴消化道症状的焦虑性神经症的中药丸及其制备方法 |
CN114767823A (zh) * | 2022-04-13 | 2022-07-22 | 黄东生 | 治疗胃痞病的中药及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102038715B (zh) | 2014-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102058480B (zh) | 一种口服泡腾片及其制备方法 | |
CN1872217B (zh) | 一种治疗头痛的药物及其制备方法 | |
CN102038715B (zh) | 一种中药溶散片剂及制备方法 | |
CN102362966A (zh) | 川贝枇杷药物组合物及其制备方法 | |
CN101091774A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN101194964A (zh) | 一种治疗头痛的包衣片剂及其制备方法 | |
CN100443098C (zh) | 一种治疗妇科疾病的药物 | |
CN1330318C (zh) | 压制法制备丸剂的工艺 | |
CN1872232B (zh) | 治疗脑血管疾病的药物组合物及其制备方法 | |
CN103735871A (zh) | 一种治疗神经衰弱的中药组合物及其制备方法 | |
CN102579670A (zh) | 一种预防和治疗功能性消化不良和便秘的中药组合物 | |
CN107854671A (zh) | 阿那日系列蒙药胃内漂浮缓释制剂及其制备方法 | |
CN1413697A (zh) | 中药六味地黄制剂的生产方法 | |
CN100420471C (zh) | 滋肾养肺的中药口服制剂及其制备方法 | |
CN104055963B (zh) | 一种减脂中药组合物及制备方法 | |
CN102058771A (zh) | 一种治疗失眠的中药制剂及其制备方法 | |
CN102240325A (zh) | 用于治疗肝炎的中药分散片及其制备方法 | |
CN100374132C (zh) | 治疗妇女更年期综合症的中西药复方制剂及其制备方法 | |
CN105596435A (zh) | 一种祛痰止咳的药物组合物及其制备方法 | |
CN101194945A (zh) | 一种治疗头痛的片剂及其制备方法 | |
CN101683361A (zh) | 以中药复方为制剂原料的胃内漂浮型缓释片剂及其制备 | |
CN103463453A (zh) | 一种金钗石斛片剂及其提取、制备方法 | |
CN104645055A (zh) | 一种治疗肥胖症合并高血脂症的中药组合物及其用途 | |
CN100430083C (zh) | 调经祛斑丸及制备方法 | |
CN104435447B (zh) | 一种葛山降脂缓释制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Applicant after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Applicant before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: TIANJIN TASLY PHARMACEUTICAL CO., LTD. TO: TASLY PHARMACEUTICAL GROUP CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140115 Termination date: 20171016 |